PD-L1 and HER2 expression in gastric cancer (GC) patients (pts) using cell-free RNA (cfRNA).

被引：3
|
作者：
Shen, James Yu Chang
Usher, Joshua
Samberg, David
Ishiba, Toshiyuki
Danenberg, Kathleen
Lenz, Heinz-Josef
Barzi, Afsaneh
机构：
[1] USC, LAC USC Med Ctr, Keck Sch Med, Los Angeles, CA USA
[2] Liquid Genom Inc, Torrance, CA USA
[3] Univ Southern Calif, Los Angeles, CA USA
[4] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e15539
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15539
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Use of cell-free circulating RNA (cfRNA) levels in plasma and expression of HER2 and PD-L1 to monitor disease status in metastatic cancer patients.
    Raez, Luis E.
    Danenberg, Kathleen
    Castrellon, Aurelio Bartolome
    Velez, Michel
    Usher, Joshua L.
    Rabizadeh, Shahrooz
    Jaimes, Yolanda S.
    Hunis, Brian
    Habaue, Cheryl
    Danenberg, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Use of cell-free circulating RNA and expression of PD-L1 and HER2 in plasma to monitor and predict clinical response in metastatic breast cancer patients
    Castrellon, Aurelio B.
    Velez, Michel
    Raez, Luis E.
    Danenberg, Kathleen
    Rabizadeh, Shahrooz
    Usher, Joshua
    Jaimes, Yolanda
    Hunis, Brian
    Bittencourt, Ana C.
    Milillo, Adriana
    Blaya, Marcelo
    Habaue, Cheryl
    Danenberg, Peter V.
    CANCER RESEARCH, 2018, 78 (04)
  • [3] PD-L1 and HER2 expression in gastric adenocarcinoma and their prognostic significance
    Lian, Jie
    Zhang, Guanjun
    Zhang, Yun
    Liu, Heng
    Zhang, Jiaojiao
    Nan, Pengfei
    Tian, Wei
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (10) : 1419 - 1427
  • [4] Detection of PD-L1 amplification using circulating cell-free DNA in gastric cancer patients
    Konishi, Hirotaka
    Fujita, Yuji
    Matsubara, Daiki
    Ogino, Shinpei
    Shoda, Katsutoshi
    Arita, Tomohiro
    Kosuga, Toshiyuki
    Komatsu, Shuhei
    Shiozaki, Atsushi
    Okamoto, Kazuma
    Otsuji, Eigo
    CANCER SCIENCE, 2018, 109 : 483 - 483
  • [5] Use of Cell-Free Circulating RNA (cfRNA) Expression of PD-L1 and ERCC1 in Plasma to Monitor Response to Therapy in NSCLC
    Raez, L.
    Danenberg, K.
    Castrellon, A.
    Rabizadeh, S.
    Usher, J.
    Jaimes, Y.
    Hunis, B.
    Dietrich, M.
    Habaue, C.
    Danenberg, P.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2089 - S2090
  • [6] The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression
    Jing, Xiaoqian
    Luo, Zhiping
    Wu, Jiayan
    Ye, Feng
    Li, Jianfang
    Song, Zijia
    Zhang, Yaqi
    Shi, Minmin
    Sun, Huaibo
    Fang, Yi
    Jiang, Yimei
    Ji, Xiaopin
    CANCER MEDICINE, 2023, 12 (24): : 21905 - 21919
  • [7] Exploration of different immunogenomic TMEs in gastric cancer based on HER2 and PD-L1 expression
    Gu, Do-Eon
    Kwon, Woo Sun
    Lee, Choong-Kun
    Kim, Hyunki
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Significance of Detection of the HER2 Gene and PD-1/PD-L1 in Gastric Cancer
    Yun, Tian
    Wang, Sunan
    Jiang, Bo
    Wang, Changsong
    Meng, Nianlong
    Yuan, Xutao
    Wang, Yangkun
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [9] Clinicopathological Characteristics and Prognostic Value of HER2, PD-L1 and MSI Expression in Curative Resectable Gastric Cancer Patients
    Pereira, M. A.
    Ramos, M. F.
    Faraj, S. F.
    Dias, A. R.
    Cirqueira, C. D.
    Charruf, A. Z.
    Perrotta, F. S.
    Mello, E. S.
    Zilberstein, B.
    Cecconello, I.
    Yagi, O. K.
    Alves, V. A.
    Junior, U. R.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S190 - S190
  • [10] Plasma Cell-Free RNA PD-L1 Expression and Clinical Outcomes With Immunotherapy
    Jayananda, S.
    Muzaffar, M.
    Namireddy, P.
    Sharma, N.
    Walker, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (02): : E9 - E9
12345